ACTIVE

APOTHEEK CHARLOTTE SULMON

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result4,4 k €-57,8 %over 1 year

Gross margin160,3 k €-4,0 %over 1 year

Equity230,7 k €+1,9 %over 1 year

Workforce1,2 ETP-25,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK CHARLOTTE SULMON is a Private limited company incorporated in 1987. Its registered office is in Zwevegem. It employs on average 1,2 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0432.086.993
Incorporation: 01/10/1987
Legal form: Private limited company
Registered office: Otegemstraat(Z) 5
8550 Zwevegem · FlandreSee on map
Contributed capital: 18 600,00 €
Latest accounts: 30/06/2025
Average workforce: 1,2 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 13 financial years

	2025		2024		2023		2022		2020
Income statement
Gross margin	160,3 k €	-4.0%	167 k €	+11.9%	149,3 k €	-42.8%	261,1 k €	+64.2%	159 k €
EBITDA	66,7 k €	-6.3%	71,1 k €	+39.3%	51,1 k €	-62.1%	134,6 k €	+52.1%	88,5 k €
Operating result	20 k €	-20.7%	25,3 k €	+379%	5,3 k €	-95.3%	112,4 k €	+39.0%	80,9 k €
Net result	4,4 k €	-57.8%	10,4 k €	+2635%	-410,8 €	-100%	92,2 k €	+28.1%	72 k €
Balance sheet
Equity	230,7 k €	+1.9%	226,3 k €	-8.0%	245,9 k €	-0.2%	246,3 k €	+59.9%	154,1 k €
Total assets	621,6 k €	-9.4%	685,9 k €	+1.4%	676,3 k €	-2.6%	694,3 k €	+91.6%	362,4 k €
Cash	71,2 k €	+49.7%	47,5 k €	-5.3%	50,2 k €	-31.5%	73,3 k €	-13.2%	84,4 k €
Debts	384,3 k €	-15.2%	453,4 k €	+5.3%	430,4 k €	-2.7%	442,5 k €	+118%	203 k €
Other
Workforce	1,2 ETP	-25.0%	1,6 ETP	-15.8%	1,9 ETP	+35.7%	1,4 ETP	-6.7%	1,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 25 ended

Active mandates

Felaudart

Director · since 28 septembre 2021 · 0695.619.563

Represented by Charlotte SULMON

Active

Ended mandates

Felaudart

Director · since 30 juin 2018 · 0695.619.563

Represented by Charlotte SULMON

Ended

Felaudart

Manager · since 30 juin 2018 · 0695.619.563

Represented by Charlotte Sulmon

Ended

Kristien VANNESTE

Manager · since 01 septembre 2015 · until 30 septembre 2015

Ended

CARDOEN PHARMA

Manager · since 13 juin 2014 · until 30 septembre 2014 · 0422.123.016

Represented by Pieter CARDOEN

Ended

Other companies at this address

Otegemstraat(Z) 5 8550 Zwevegem

Company	CBE no.
Felaudart● Active	0695.619.563
GROEP SULMON● Active	0778.525.760

Full financial information

Source · NBB

	2025	2024	2023	2022	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/10/2020	01/10/2019	01/10/2018
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/09/2020	30/09/2019
Length of the financial year	12 months	12 months	12 months	21 months	12 months	12 months
Filing date	31/01/2026	28/01/2025	31/01/2024	31/01/2023	06/04/2021	26/02/2020
General meeting	27/12/2025	28/12/2024	30/12/2023	31/12/2022	20/03/2021	25/01/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	27/12/2025	31/01/2026	Dutch	PDF
Abridged model	30/06/2024	28/12/2024	28/01/2025	Dutch	PDF
Abridged model	30/06/2023	30/12/2023	31/01/2024	Dutch	PDF
Abridged model	30/06/2022	31/12/2022	31/01/2023	Dutch	PDF
Abridged model	30/09/2020	20/03/2021	06/04/2021	Dutch	PDF
Abridged model	30/09/2019	25/01/2020	26/02/2020	Dutch	PDF
Abridged model	30/09/2018	16/02/2019	25/02/2019	Dutch	PDF
Micro model	30/09/2017	27/01/2018	20/02/2018	Dutch	PDF
Abridged model	30/09/2016	28/01/2017	01/02/2017	Dutch	PDF
Abridged model	30/09/2015	30/01/2016	02/02/2016	Dutch	PDF
Abridged model	30/09/2014	31/01/2015	02/02/2015	Dutch	PDF
Abridged model	30/09/2013	25/01/2014	18/02/2014	Dutch	PDF
Abridged model	30/09/2012	26/01/2013	08/03/2013	Dutch	PDF
Abridged model	30/09/2011	03/04/2012	20/04/2012	Dutch	PDF
Abridged model	30/09/2010	11/03/2011	15/04/2011	Dutch	PDF
Abridged model	30/09/2009	30/01/2010	19/03/2010	Dutch	PDF
Abridged model	30/09/2008	31/01/2009	02/03/2009	Dutch	PDF
Abridged model	30/09/2007	26/01/2008	19/03/2008	Dutch	PDF
Abridged model	30/09/2006	27/01/2007	20/02/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 25 ended

Active mandates

Felaudart

Director · since 28 septembre 2021 · 0695.619.563

Represented by Charlotte SULMON

Active

Ended mandates

Felaudart

Director · since 30 juin 2018 · 0695.619.563

Represented by Charlotte SULMON

Ended

Felaudart

Manager · since 30 juin 2018 · 0695.619.563

Represented by Charlotte Sulmon

Ended

Kristien VANNESTE

Manager · since 01 septembre 2015 · until 30 septembre 2015

Ended

CARDOEN PHARMA

Manager · since 13 juin 2014 · until 30 septembre 2014 · 0422.123.016

Represented by Pieter CARDOEN

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/10/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
PDF
Other30/08/2018
BENAMING - DOEL
PDF
Mandates16/07/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares22/01/2018
KAPITAAL - AANDELEN
PDF
Mandates18/09/2015
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/10/2014
BENAMING - ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates18/07/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/05/2011
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 20254,4 k €↓
2024
Annual accounts 202410,4 k €↑
2023
Annual accounts 2023-410,8 €↓
2022
Annual accounts 202292,2 k €↑
2020
Annual accounts 202072 k €↑
2019
Annual accounts 201930,3 k €↑
2018
Annual accounts 201826,3 k €↑
2017
Annual accounts 201718,7 k €↓
2016
Annual accounts 201665,5 k €↑
2015
Annual accounts 201549,8 k €↑
2014
Annual accounts 201435,6 k €↓
2008
Annual accounts 200850 k €↑
2007
Annual accounts 200731,9 k €
01/10/1987
IncorporationPrivate limited company

APOTHEEK CHARLOTTE SULMON

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline